Clinical Trial Update: High (100mg) Versus Standard (60mg) Loading Dose of Prasugrel in Patients With ST-elevation Myocardial Infarction (STEMI), Undergoing Primary Percutaneous Coronary Intervention (PCI) [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing a 100 mg prasugrel loading dose to a 60 mg loading dose in ST-elevation myocardial infarction patients undergoing primary PCI has comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• St-elevation Myocardial Infarction

Drugs mentioned

• PRASUGREL (prasugrel)

Snippet

Sponsor: University of Patras | Conditions: Platelet Reactivity | Phase 3 | Status: COMPLETED